Heparanase contributes to psoriatic lesions through crosstalk with IL-17 pathway
Psoriasis is a chronic inflammatory disease that is considered by a network of immunocytes and cytokines. Among all, Th17 cells-derived IL-17 is a critical driving factor in the pathogenesis of psoriasis. Recently, disruption of the extracellular matrix was found to be related to psoriasis progressi...
Saved in:
Main Authors: | Chengyao Zhu (Author), Yunqin Ren (Author), Hongliang Yao (Author), Bo Feng (Author), Lunfei Liu (Author), Min Zheng (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of heparanase in ARDS through autophagy and exosome pathway (review)
by: Fei Feng, et al.
Published: (2023) -
Role of heparanase in pulmonary hypertension
by: Lin-Jun Wang, et al.
Published: (2023) -
Dual inhibition of IL-17A and IL-17F in psoriatic disease
by: Helena Iznardo, et al.
Published: (2021) -
New insights into host‐microbiome crosstalk in psoriatic skin
by: Jesus Miguens‐Blanco, et al.
Published: (2022) -
Chinese Medicine Formula PSORI-CM02 Alleviates Psoriatic Dermatitis via M-MDSCs and Th17 Crosstalk
by: Jingwen Deng, et al.
Published: (2021)